Browsing by Author "Mostic Stanisic, Danka (57219173539)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Antiplatelet Drugs Use in Pregnancy—Review of the Current Practice and Future Implications(2024) ;Antonijevic, Nebojsa (6602303948) ;Gosnjic, Nikola (58627100600) ;Marjanovic, Marija (56437423000) ;Antonijevic, Jovana (57205437166) ;Culafic, Milica (55881915300) ;Starcevic, Jovana (59188693800) ;Plavsic, Milana (59189004800) ;Mostic Stanisic, Danka (57219173539) ;Uscumlic, Ana (56807174000) ;Lekovic, Zaklina (58626922600)Matic, Dragan (25959220100)When clinicians opt for antithrombotic therapy to manage or prevent thrombotic complications during pregnancy, it is imperative to consider the unique physiological state of the pregnant woman’s body, which can influence the pharmacokinetics of the drug, its ability to traverse the placental barrier, and its potential teratogenic effects on the fetus. While the efficacy and safety of aspirin during pregnancy have been relatively well-established through numerous clinical studies, understanding the effects of newer, more potent antiplatelet agents has primarily stemmed from individual clinical case reports necessitating immediate administration of potent antiplatelet therapy during pregnancy. This review consolidates the collective experiences of clinicians confronting novel thrombotic complications during pregnancy, often requiring the use of dual antiplatelet therapy. The utilization of potent antiplatelet therapy carries inherent risks of bleeding, posing threats to both the pregnant woman and the fetus, as well as the potential for teratogenic effects on the fetus. In the absence of official guidelines regarding the use of potent antiplatelet drugs in pregnancy, a plethora of cases have demonstrated the feasibility of preventing recurrent thrombotic complications, mitigating bleeding risks, and successfully managing pregnancies, frequently culminating in cesarean deliveries, through meticulous selection and dosing of antiplatelet medications. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Effect of regional vs general anesthesia on vital functions after cesarean section: a single center experience(2022) ;Mostic Stanisic, Danka (57219173539) ;Kalezic, Nevena (6602526969) ;Rajovic, Nina (57218484684) ;Ilic Mostic, Tatjana (6503948501) ;Cumic, Jelena (57209718077) ;Stanisavljevic, Tamara (57252613700) ;Beleslin, Aleksandra (57895738000) ;Stulic, Jelena (57209247701) ;Rudic, Ivana (57203842180) ;Divac, Nevena (23003936900) ;Milic, Natasa (7003460927)Stojanovic, Radan (7003903083)Background: The aim was to determine the effect of regional anesthesia (RA) on postoperative vital functions in contrast to general endotracheal anesthesia (GEA) after the cesarean section. Methods: Prospective cohort study included consecutive term pregnant women delivered by cesarean section (GEA, n = 284; RA, n = 249). Results: Higher levels of blood pressure and heart rate, as well as lower levels of pulse oximetry were found for GEA in contrast to RA (p < 0.001). The application of RA presented less side-effects (p < 0.05). Conclusions: RA for cesarean section should be preferred when balancing the risks and benefits for the mother and fetus. © 2022 Informa UK Limited, trading as Taylor & Francis Group.
